News

Yahoo Finance6d
Basilea reports presentation of new data for fosmanogepix, isavuconazole (Cresemba®) and ceftobiprole (Zevtera®) at ESCMID Global 2025
Further presentations covered the antifungal isavuconazole (Cresemba ®) and the antibiotic ceftobiprole (Zevtera ®). Dr. Marc Engelhardt, Chief Medical Officer of Basilea, said: “Invasive ...
Morningstar6d
Basilea reports presentation of new data for fosmanogepix, isavuconazole (Cresemba®) and ceftobiprole (Zevtera®) at ESCMID Global 2025
Further presentations covered the antifungal isavuconazole (Cresemba®) and the antibiotic ceftobiprole (Zevtera®). Dr. Marc Engelhardt, Chief Medical Officer of Basilea, said: “Invasive fungal ...
manilatimes6d
Basilea reports presentation of new data for fosmanogepix, isavuconazole (Cresemba®) and ceftobiprole (Zevtera®) at ESCMID Global 2025
Further presentations covered the antifungal isavuconazole (Cresemba ®) and the antibiotic ceftobiprole (Zevtera ®). Dr. Marc Engelhardt, Chief Medical Officer of Basilea, said: "Invasive fungal ...
Yahoo Finance5d
Basilea shareholders approve all proposals of the board of directors at the annual general meeting
We have successfully launched two hospital brands, Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of bacterial infections. In addition, we have preclinical ...
manilatimes6d
Start of Day Message
LONDON, 16 Apr. 2025 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information ...
Medscape3d
Family Medicine News
Abatacept Might Be First-Ever Treatment for Rare Immune Deficiency Some devastating aspects of common variable immune deficiency are a result of a defect in trafficking of the immune down ...